Goldman Sachs Talks podcast

Amicus Therapeutics CEO John Crowley

0:00
30:42
Recuar 15 segundos
Avançar 15 segundos
In this episode of Talks at GS, John F. Crowley, chairman and CEO of Amicus Therapeutics discusses his leadership at Amicus Therapeutics, his efforts to develop cutting-edge treatments for rare diseases and disorders, and his perspective as a biotech innovator on the global response to the pandemic.

Mais episódios de "Goldman Sachs Talks"